T. Rowe Price Associates
CVS icon

T. Rowe Price Associates’s CVS Health CVS Stock Holding History

T. Rowe Price Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,000
Closed -$12.4M – 2586
2018
Q1 		$12.4M Hold
200,000
– – ﹤0.01% 1296
2017
Q4 		$14.5M Hold
200,000
– – ﹤0.01% 1276
2017
Q3 		$16.3M Buy
+200,000
New +$15.8M ﹤0.01% 1244

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates's CVS Position: Q1 2026 in Review

T. Rowe Price Associates increased its CVS Health (CVS) stake by 45% in Q1 2026, buying an estimated $565M and bringing the position to 23,783,145 shares worth $1.71B. The position accounts for 0.2% of the portfolio, ranked #106.

T. Rowe Price Associates first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.12B in Q3 2015. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • T. Rowe Price Associates held 23,783,145 shares of CVS Health worth $1.71B as of Q1 2026.
  • T. Rowe Price Associates bought 7,339,159 CVS Health shares in Q1 2026, an estimated $565M.
  • CVS Health made up 0.2% of T. Rowe Price Associates's portfolio in Q1 2026, its #106 holding.
  • T. Rowe Price Associates first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's CVS Health position peaked at $2.12B in Q3 2015.
  • 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.